CWBR CWBR

CohBar Stock Price

FREE CWBR REPORT

2.19
0.11 (5.29%)
2.19
Volume 18,854
Bid Price 2.08
Ask Price 2.09
News -
Day High 2.23

Low
1.50

52 Week Range

High
11.01

Day Low 2.05
Company Name Stock Ticker Symbol Market Type
CohBar Inc CWBR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.11 5.29% 2.19 16:14:46
Open Price Low Price High Price Close Price Prev Close
2.08 2.05 2.23 2.19 2.08
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
169 18,854 $ 2.16 $ 40,663 - 1.50 - 11.01
Last Trade Time Type Quantity Stock Price Currency
16:00:00 7 $ 2.18 USD

Period:

Draw Mode:

CohBar Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.37M 2.91M 2.91M $ - $ - -6.92 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 357.22k 8.00%

more financials information »

CohBar News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CWBR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.042.232.002.1112,7320.157.35%
1 Month1.802.411.602.0534,3700.3921.67%
3 Months2.152.411.501.8830,5860.041.86%
6 Months5.406.571.504.45183,927-3.21-59.44%
1 Year10.06811.011.506.56323,773-7.88-78.25%
3 Years75.30144.001.5033.35774,851-73.11-97.09%
5 Years198.30323.671.5040.42500,490-196.11-98.9%

CohBar Description

CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drug such as CB4209 and CB4211, SHLP-6, SHLP-2 and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operation of the group is functioned through the region of United States.